Incubation period 2026-10-14
The incubation period is the interval from infection to symptom onset in a person who develops symptoms. Its probability distribution describes onset times, not the full timing of infectiousness. Exposure may only be known to fall in an interval, requiring a corresponding observation model when estimating this distribution.
Two distinct issues are:
Thus the comparison must account for uncertainty in both its exposure denominator and its observed-disease numerator; a very small sampling p-value does not remove those model uncertainties.
Under the proposed exposure-only model, suppose a unit of infectious exposure has the same probability of producing an ascertained onset in either cohort. Conditional on the total of onsets, the allocation is a binomial distribution with younger-cohort probability
Thus the expected cohort counts are and , respectively, whereas the observed allocation is reversed. The Pearson chi-squared goodness-of-fit test gives
With one degree of freedom its approximate p-value is ; the exact upper binomial distribution tail is approximately . These are exceptionally incompatible with proportional allocation. Equivalently, the observed onset count per exposure unit is four times larger in the younger cohort:
Under the stated common-risk exposure model, the observed counts are not consistent with the early exposure period as their sole explanation. This does not identify the source of the discrepancy, or prove a particular later exposure caused it. The inference also requires comparable ascertainment and a common fraction of exposure-derived cases manifesting by the observation date. Age-independent incubation periods alone do not guarantee that fraction when the two cohorts' exposure profiles within the decade differ; decade totals omit that timing information. The reasoning concerns the hypothetical historical BSE/vCJD model, not an estimate of current disease risk.
Quarantine restricts contacts of exposed people whose infection status is uncertain and monitors them for illness, reducing opportunities for transmission before infection is recognized. Recognized cases are managed by isolation rather than treated as merely uncertain exposures. Duration must be measured from the last possible infection-producing exposure, or otherwise account for uncertainty in exposure time. The mathematical calculations below concern the incubation period among infected people who develop symptoms, not a complete infectiousness model.
With a credible hard endpoint , the truncated distribution has
A duration then covers all symptom-onset times under that model, provided the exposure time is correctly specified. If a nonzero late-onset probability is accepted, solve
The calculation is appropriate when external biological evidence genuinely supports a hard maximum, or when a deliberately bounded model is justified for the population being considered. Truncation caused by a study's ascertainment window instead requires an observation correction: it does not prove that the disease has a hard biological endpoint. Nor does guarantee that future cases will develop symptoms by the current sample maximum. Endpoint and nuisance-parameter uncertainty need to enter a conservative duration calculation.
For an untruncated gamma distribution, lognormal distribution or other model with an unbounded upper tail, no finite duration eliminates the modeled late-onset probability. Choose a tail tolerance and solve
This is appropriate when a hard endpoint is unsupported and rare long incubation times remain possible. One can estimate a high quantile, assess its uncertainty and balance the modeled residual probability against the costs of longer restrictions. Different tail families can give very different high quantiles even when they fit the central observations similarly, which makes the model dependence seen in part b operationally relevant.
If an individual has already remained symptom-free for time units after a known exposure, a conditional additional duration instead uses , where is the relevant survivor function and . This conditions on being an infected eventual symptomatic case. Incubation data alone do not describe asymptomatic infection, the timing of infectiousness or compliance with restrictions; symptom surveillance, testing where informative and a transmission model may therefore be needed to translate late onset into an actual release-risk calculation. Use a hard bound only when it is supported; otherwise quantify and allow for the upper-tail uncertainty.
Write and . Until quarantine and while , division of the equations gives
Integration from the initial state yields the first integral
Let be the susceptible count at the first time . It is the root of an equation reached on the decreasing- outbreak trajectory of
For a strictly rising threshold crossing this is the larger admissible root of an equation, with ; if the threshold equals the peak, . The assumption that quarantine is reached selects the physically relevant branch and excludes a merely hypothetical declining-branch crossing after an earlier one.
Since there is no incubation period here, all removals from have already become infection cases by quarantine. No further susceptible individuals are infected after isolation. The requested number among the initially susceptible individuals is therefore
At the retained order define . Neglecting terms of order in the incidence correction gives
Dividing and expanding consistently,
Thus the susceptible count at the first threshold crossing obeys the same retained-order equation as before:
It is important to distinguish completed case transfers at quarantine from all infections already initiated. Let the quarantine time be . Isolation prevents exposures after , but animals exposed during still finish their incubation period during . Their number, in the printed bookkeeping, is
The infection cases transferred by time among the initial class number . Adding those pending infection cases gives the eventual number who catch the infectious disease:
This adds only infections caused by exposures before isolation; it does not allow secondary transmission after quarantine. If one asks instead only for the transfers completed by the instant of quarantine, the answer is . The distinction is necessary because the model keeps incubating animals in its compartment.
The delayed influx represents animals exposed one incubation period earlier who enter the infective individual compartment now. They die at the instantaneous rate once in that compartment. The displayed bookkeeping removes an animal from at the same delayed time that it enters , preserving .
For this bookkeeping, must include the exposed animals which have not yet completed incubation period. If were instead defined as strictly unexposed susceptible individuals, its loss term would be the current exposure rate and a separate latent compartment would be needed. The calculations here follow the printed delay differential equation. A full initial-value problem for a delay differential equation also needs a history on ; the following small-delay expansion of an epidemic transfer rate concerns a smooth compatible history and the regular regime assumed by the question.
When exposed animals remain in a not-yet-infective compartment for a fixed incubation period , stopping all new exposure does not cancel the pending case transfers. At isolation time , their number is for smooth profiles. Eventual cases therefore include this pipeline in addition to case transfers already completed by . The interpretation depends on the compartment definition: a strictly unexposed susceptible compartment would instead lose these animals at exposure.
Quarantine 2026-10-14
Quarantine restricts contacts of exposed individuals whose infection status is uncertain, with monitoring to detect illness. It differs from isolation of recognized infected or ill individuals. An incubation period quantile can enter a duration calculation, but assumptions about exposure time, symptom detection and infectiousness are needed before the calculation describes transmission risk.
A human prion disease associated with exposure to the BSE agent. Exposure totals and clinical-onset totals measure different stages of the disease process; incubation periods and ascertainment affect their relationship.